Project/Area Number |
11357002
|
Research Category |
Grant-in-Aid for Scientific Research (A)
|
Allocation Type | Single-year Grants |
Section | 展開研究 |
Research Field |
General medical chemistry
|
Research Institution | KYOTO UNIVERSITY |
Principal Investigator |
NODA Makoto GRADUATE SCHOOL OF MEDICINE, KYOTO UNIVERSITY, PROFESSOR, 医学研究科, 教授 (30146708)
|
Co-Investigator(Kenkyū-buntansha) |
KITAYAMA Hitoshi GRADUATE SCHOOL OF MEDICINE, KYOTO UNIVERSITY, ASSISTANT PROFESSOR, 医学研究科, 助教授 (30231286)
|
Project Period (FY) |
1999 – 2001
|
Project Status |
Completed (Fiscal Year 2001)
|
Budget Amount *help |
¥31,500,000 (Direct Cost: ¥29,700,000、Indirect Cost: ¥1,800,000)
Fiscal Year 2001: ¥7,800,000 (Direct Cost: ¥6,000,000、Indirect Cost: ¥1,800,000)
Fiscal Year 2000: ¥9,800,000 (Direct Cost: ¥9,800,000)
Fiscal Year 1999: ¥13,900,000 (Direct Cost: ¥13,900,000)
|
Keywords | retroviral vector / TGF-β / TMX / thioredoxin / ER stress / bleomycin / c-IAP2 / X-ray-responsive genes / レトロウイルスベクター / エンハンサートラップ / X線 / NF-kB / Bax / 遺伝子発現 / エンハンサー・トラップ / シグナル伝達 / TGF-β |
Research Abstract |
As applications of the newly developed enhancer trap system using a retroviral vector (pROSA-nGBT), we screened genes responsive to TGF-β or bleomycin, succeeded in isolating multiple genes of interest in each case, and could publish a part of these results. One of the TGF-β-responsive genes was found to encode a novel, thioredoxin-related transmembrane protein localized in the endoplasmic reticulum (ER) and was suggested to be a molecule involved in the management of ER stress. One of the genes responsive to bleomycin, a drug inducing DNA double strand break, was identified as C-IAP2 know to be involved in apoptosis. Since the promoter of this gene was found also to respond to therapeutic dosages of ionizing radiation, its application in radiation gene therapy is an interesting possibility and warrants further investigation.
|